(Sharecast News) - Fusion Antibodies said on Monday that it has entered into an agreement to transfer ownership of certain background intellectual property to an existing client, generating a one-off payment and supporting continued collaboration on antibody development.
The AIM-traded antibody discovery specialist said the agreement with Finn Therapeutics covered a...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE